220 related articles for article (PubMed ID: 23160117)
1. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis.
Owczarek D; Cibor D; Głowacki MK; Cieśla A; Mach P
Pol Arch Med Wewn; 2012; 122(12):616-23. PubMed ID: 23160117
[TBL] [Abstract][Full Text] [Related]
2. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha and soluble TNF-alpha receptor responses in young vs. middle-aged males following eccentric exercise.
Arroyo E; Wells AJ; Gordon JA; Varanoske AN; Gepner Y; Coker NA; Church DD; Fukuda DH; Stout JR; Hoffman JR
Exp Gerontol; 2017 Dec; 100():28-35. PubMed ID: 29038027
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus.
Ferreira GA; Teixeira AL; Calderaro DC; Sato EI
Clin Exp Rheumatol; 2016; 34(1):42-8. PubMed ID: 26574625
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokine kinetics to single bouts of acute moderate and intense aerobic exercise in women with active and inactive systemic lupus erythematosus.
Perandini LA; Sales-de-Oliveira D; Mello S; Camara NO; Benatti FB; Lima FR; Borba E; Bonfa E; Roschel H; Sá-Pinto AL; Gualano B
Exerc Immunol Rev; 2015; 21():174-85. PubMed ID: 25825870
[TBL] [Abstract][Full Text] [Related]
7. Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.
Loganes C; Pin A; Naviglio S; Girardelli M; Bianco AM; Martelossi S; Tommasini A; Piscianz E
World J Gastroenterol; 2016 Nov; 22(41):9117-9126. PubMed ID: 27895399
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis.
Ribeiro CM; Oliveira SR; Alfieri DF; Flauzino T; Kaimen-Maciel DR; Simão ANC; Maes M; Reiche EMV
Inflamm Res; 2019 Dec; 68(12):1049-1059. PubMed ID: 31559449
[TBL] [Abstract][Full Text] [Related]
9. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
[TBL] [Abstract][Full Text] [Related]
10. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.
Gómez-Banoy N; Cuevas V; Higuita A; Aranzález LH; Mockus I
J Diabetes Complications; 2016 Jul; 30(5):852-7. PubMed ID: 27068267
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects.
Fernández-Real JM; Gutiérrez C; Ricart W; Castiñeira MJ; Vendrell J; Richart C
Atherosclerosis; 1999 Oct; 146(2):321-7. PubMed ID: 10532687
[TBL] [Abstract][Full Text] [Related]
12. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis.
Bessa TF; Cordeiro CA; Gonçalves RM; Young LH; Campos WR; Oréfice F; Teixeira AL
Braz J Infect Dis; 2012; 16(6):540-4. PubMed ID: 23141990
[TBL] [Abstract][Full Text] [Related]
14. Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease.
Moreira JM; da Silva AN; Marciano Vieira ÉL; Teixeira AL; Kummer AM; Simões E Silva AC
Pediatr Nephrol; 2019 Feb; 34(2):349-352. PubMed ID: 30374604
[TBL] [Abstract][Full Text] [Related]
15. Significant Induction of Soluble TNFR2 Compared with TNFR1 in Serum Samples of HIV Patients with or without Antiretroviral Medication.
Sarfo B; Haile ZT; Deletsu S; Mensah EA; Bonney EY
Infect Disord Drug Targets; 2020; 20(2):175-181. PubMed ID: 30324895
[TBL] [Abstract][Full Text] [Related]
16. Plasma histamine and tumour necrosis factor-alpha levels in Crohn's disease and ulcerative colitis at various stages of disease.
Hagel AF; de Rossi T; Konturek PC; Albrecht H; Walker S; Hahn EG; Raithel M
J Physiol Pharmacol; 2015 Aug; 66(4):549-56. PubMed ID: 26348079
[TBL] [Abstract][Full Text] [Related]
17. Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis.
Patel M; Oni L; Midgley A; Smith E; Tullus K; Marks SD; Jones CA; Pilkington C; Beresford MW
Lupus; 2016 Aug; 25(9):1040-4. PubMed ID: 26854079
[TBL] [Abstract][Full Text] [Related]
18. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.
Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ
Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder.
Barbosa IG; Huguet RB; Mendonça VA; Sousa LP; Neves FS; Bauer ME; Teixeira AL
Eur Arch Psychiatry Clin Neurosci; 2011 Mar; 261(2):139-43. PubMed ID: 20446090
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia.
Noto C; Gadelha A; Belangero SI; Spindola LM; Rocha NP; de Miranda AS; Teixeira AL; Cardoso Smith MA; de Jesus Mari J; Bressan RA; Brietzke E
J Psychiatr Res; 2013 Apr; 47(4):467-71. PubMed ID: 23360651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
